Individuals 65 years of age or older currently account for over eighty percent of all cardiovascular disease-related deaths. With advances and breakthroughs in modern medicine that are allowing people to live longer, the number of older adults in this country will continue to grow exponentially over
Cardiovascular Disease in the Elderly:Third Edition, Revised and Expanded
โ Scribed by Wilbert S. Aronow, Jerome L. Fleg
- Publisher
- Informa Healthcare
- Year
- 2004
- Tongue
- English
- Leaves
- 871
- Edition
- 3
- Category
- Library
No coin nor oath required. For personal study only.
โฆ Synopsis
Certain to become the most trusted source in geriatric cardiology, this Third Edition compiles the latest studies and expertise on the epidemiology, pathophysiology, and management of cardiovascular disease in the elderly patient-tracking the rapid pace of innovation in the field with in-depth explorations of the most recent clinical trials and advances in vascular biology, cardiology, and cardiovascular surgery for influential developments in disease prevention and management.
๐ SIMILAR VOLUMES
<P>Individuals 65 years of age or older currently account for over eighty percent of all cardiovascular disease-related deaths. With advances and breakthroughs in modern medicine that are allowing people to live longer, the number of older adults in this country will continue to grow exponentially o
Individuals 65 years of age or older currently account for over eighty percent of all cardiovascular disease-related deaths. With advances and breakthroughs in modern medicine that are allowing people to live longer, the number of older adults in this country will continue to grow exponentially over
A panel of clinicians, researchers, and leaders in the field review and discuss the latest findings on the pathophysiology, diagnosis, and management of cardiovascular disease in the older patient. The authors explain the physiological changes associated with the normal aging process that may lead t
<p>As the number, availability, and often the invasiveness and associated risks of new cardiovascular treatments expands, health care providers are increasingly called upon to decide whether or not to recommend these therapies to the increasing numbers of older patients with cardiovascular disease.
<p>That geriatric cardiology has become a science and clinical discipline in its own rights is beyond dispute. Most cardiac disorders present with different symptoms and signs, require a different diagnostic and therapeutic approach, and also have a different prognosis in the elderly as compared to